Physician profile
Aungel L Evans
NPI 1952577397
$9,924.13
in general payments reported to CMS, 2019-2025
30 companies · $6,331 in 2025
The $6,331 reported for 2025 was more than what 94% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $69.38 · 2021: $159 · 2022: $464 · 2023: $727 · 2024: $2,026 · 2025: $6,331.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,800 · Food and Beverage: $2,088 · Education: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,800.00 |
| Food and Beverage | $2,087.58 |
| Education | $197.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $6,800.00 | 2024-2025 | Bovine Collagen |
| Organon LLC | $508.60 | 2021-2025 | Nexplanon |
| Astellas Pharma US INC | $407.30 | 2023-2025 | Veozah |
| Exeltis, USA INC. | $299.34 | 2019-2025 | Slynd |
| Sumitomo Pharma America, INC. | $279.48 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $271.04 | 2022-2025 | |
| Pfizer INC. | $180.15 | 2021-2024 | |
| Abbvie INC. | $179.63 | 2019-2023 | |
| Millicent US INC | $124.77 | 2023-2025 | Intrarosa, Femring, Femlyv |
| Therapeuticsmd, INC. | $104.69 | 2019-2022 | |
| Sage Therapeutics, LLC | $85.12 | 2025 | Zurzuvae |
| Myovant Sciences INC. | $84.92 | 2021-2022 | |
| Daiichi Sankyo INC. | $84.10 | 2024 | Injectafer |
| Myriad Women'S Health, INC. | $77.13 | 2023 | Myrisk |
| Coopersurgical, INC. | $61.82 | 2022-2025 | Supercut Hysterectomy Scissors, Paragard T 380a |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $50.19 | 2022-2025 | Perclot |
| Bayer Healthcare Pharmaceuticals INC. | $43.78 | 2023-2025 | |
| Integra Lifesciences Corporation | $33.44 | 2022-2023 | Biodoptix, Medihoney, Biofix |
| Minerva Surgical, INC | $29.23 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $26.16 | 2019 | |
| Hologic Sales and Service, LLC | $25.44 | 2024 | Aptima |
| American Regent | $25.04 | 2025 | Injectafer |
| Monaghan Medical Corporation | $23.24 | 2023 | Aerochamber |
| Meditrina | $21.49 | 2024 | |
| Innovation Technologies INC | $19.61 | 2023 | Irrisept |
| Amgen INC. | $18.33 | 2019 | |
| Evofem Biosciences, INC. | $17.17 | 2022 | |
| Agile Therapeutics, INC. | $15.50 | 2024 | Twirla |
| Exact Sciences Corporation | $14.09 | 2025 | Cologuard Collection Kit |
| Avion Pharmaceuticals | $13.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aungel Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.